These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Preclinical development and characterisation of Wong NC; Cai Y; Meszaros LK; Biersack HJ; Cook GJ; Ting HH; Mottaghy FM Am J Nucl Med Mol Imaging; 2021; 11(3):154-166. PubMed ID: 34234994 [TBL] [Abstract][Full Text] [Related]
6. Inter- and intraobserver agreement of programmed death ligand 1 scoring in head and neck squamous cell carcinoma, urothelial carcinoma and breast carcinoma. Downes MR; Slodkowska E; Katabi N; Jungbluth AA; Xu B Histopathology; 2020 Jan; 76(2):191-200. PubMed ID: 31243779 [TBL] [Abstract][Full Text] [Related]
7. Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy. Gao H; Wu Y; Shi J; Zhang X; Liu T; Hu B; Jia B; Wan Y; Liu Z; Wang F J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33203663 [TBL] [Abstract][Full Text] [Related]
8. Noninvasive Imaging of Tumor PD-L1 Expression Using [ Zhang Y; Ding Y; Li N; Wang S; Zhou S; Li R; Yang H; Li W; Qu J Mol Pharm; 2023 Jan; 20(1):690-700. PubMed ID: 36541699 [TBL] [Abstract][Full Text] [Related]
9. Retraction Note to: Inter- and intraobserver agreement of the quantitative assessment of [ Hughes DJ; Chand G; Goh V; Cook GJR EJNMMI Res; 2021 Oct; 11(1):102. PubMed ID: 34637006 [No Abstract] [Full Text] [Related]
10. Reproducibility of Lobar Perfusion and Ventilation Quantification Using SPECT/CT Segmentation Software in Lung Cancer Patients. Provost K; Leblond A; Gauthier-Lemire A; Filion É; Bahig H; Lord M J Nucl Med Technol; 2017 Sep; 45(3):185-192. PubMed ID: 28408698 [TBL] [Abstract][Full Text] [Related]
11. Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8 Ertveldt T; Meulewaeter S; De Vlaeminck Y; Olarte O; Broos K; Van Calenbergh S; Bourgeois S; Deprez J; Heremans Y; Goyvaerts C; Staels W; De Smedt S; Dewitte H; Devoogdt N; Keyaerts M; Verbeke R; Barbé K; Lentacker I; Breckpot K Theranostics; 2023; 13(15):5483-5500. PubMed ID: 37908728 [No Abstract] [Full Text] [Related]
13. Noninvasive Evaluation of Tumoral PD-L1 Using a Novel Hu B; Ma X; Shi L; Liu T; Li L; Yao M; Li C; Jia B Mol Pharm; 2024 Apr; 21(4):1977-1986. PubMed ID: 38395797 [TBL] [Abstract][Full Text] [Related]
14. High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma. Robert ME; Rüschoff J; Jasani B; Graham RP; Badve SS; Rodriguez-Justo M; Kodach LL; Srivastava A; Wang HL; Tang LH; Troncone G; Rojo F; Van Treeck BJ; Pratt J; Shnitsa I; Kumar G; Karasarides M; Anders RA Mod Pathol; 2023 May; 36(5):100154. PubMed ID: 36925069 [TBL] [Abstract][Full Text] [Related]
15. Assessment of technetium-99m labeled macroaggregated albumin rhinoscintigraphy for the measurement of nasal mucociliary transport rate: intratest, interobserver, and intraobserver reproducibility. Dostbil Z; Dag Y; Cetinkaya O; Akdag M; Tasdemir B Scientifica (Cairo); 2014; 2014():982515. PubMed ID: 24741446 [TBL] [Abstract][Full Text] [Related]
17. Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma. Rebelatto MC; Midha A; Mistry A; Sabalos C; Schechter N; Li X; Jin X; Steele KE; Robbins PB; Blake-Haskins JA; Walker J Diagn Pathol; 2016 Oct; 11(1):95. PubMed ID: 27717372 [TBL] [Abstract][Full Text] [Related]
18. Coregistered ventilation and perfusion SPECT using krypton-81m and Tc-99m-labeled macroaggregated albumin with multislice CT utility for prediction of postoperative lung function in non-small cell lung cancer patients. Ohno Y; Koyama H; Takenaka D; Nogami M; Kotani Y; Nishimura Y; Yoshimura M; Yoshikawa T; Sugimura K Acad Radiol; 2007 Jul; 14(7):830-8. PubMed ID: 17574133 [TBL] [Abstract][Full Text] [Related]
19. Investigations of (99m)Tc-labeled glucarate as a SPECT radiotracer for non-small cell lung cancer (NSCLC) and potential tumor uptake mechanism. Meng L; Xiu Y; Li Y; Xu X; Li S; Li X; Pak KY; Shi H; Cheng D Nucl Med Biol; 2015 Jul; 42(7):608-13. PubMed ID: 25890861 [TBL] [Abstract][Full Text] [Related]